Oragenics Files 8-K: Director/Officer Changes & Financials
Ticker: OGEN · Form: 8-K · Filed: Sep 2, 2025 · CIK: 1174940
Sentiment: neutral
Topics: corporate-governance, officer-changes, financial-statements
TL;DR
Oragenics 8-K: Leadership shakeup and financial updates filed.
AI Summary
Oragenics, Inc. filed an 8-K on September 2, 2025, reporting events as of September 1, 2025. The filing indicates changes related to the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. It also includes financial statements and exhibits.
Why It Matters
This filing signals potential shifts in Oragenics' leadership and corporate governance, which could impact the company's strategic direction and operational execution.
Risk Assessment
Risk Level: medium — Changes in directors and officers, along with the filing of financial statements, can indicate significant internal developments that may affect the company's future performance.
Key Players & Entities
- Oragenics, Inc. (company) — Registrant
- September 1, 2025 (date) — Date of earliest event reported
- September 2, 2025 (date) — Date of report
FAQ
What specific changes occurred regarding directors or officers?
The filing indicates events related to the departure of directors or certain officers, the election of directors, and the appointment of certain officers.
What is the exact date of the report?
The exact date of the report is September 2, 2025.
What is the earliest event date reported?
The earliest event reported is September 1, 2025.
What other items are included in this 8-K filing?
The filing also includes information on compensatory arrangements of certain officers, as well as financial statements and exhibits.
What is Oragenics, Inc.'s principal executive office address?
Oragenics, Inc.'s principal executive office is located at 1990 Main Street, Suite 750, Sarasota, FL 34236.
Filing Stats: 852 words · 3 min read · ~3 pages · Grade level 10.9 · Accepted 2025-09-02 16:50:13
Key Financial Figures
- $45,000 — al base fee for service on the Board of $45,000, pro rated for any partial years, the B
- $3,750 — s, the Board agreed to pay Ms. Giordano $3,750 per month for each of the months of Sep
Filing Documents
- form8-k.htm (8-K) — 45KB
- 0001493152-25-012562.txt ( ) — 207KB
- ogen-20250901.xsd (EX-101.SCH) — 3KB
- ogen-20250901_lab.xml (EX-101.LAB) — 33KB
- ogen-20250901_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this 2 nd day of September 2025. ORAGENICS, INC. (Registrant) BY: /s/ Janet Huffman Janet Huffman Chief Executive Officer